Multiomics screening of red blood cells (RBCs) reveals new candidate diagnostic biomarkers for acute venous thrombosis

Venous Thromboembolism (VTE) is a leading cause of cardiovascular mortality. The diagnosis of acute VTE is still based on complex imaging exams due to the lack of biomarkers. However, studies assessing the diagnostic capacity of novel biomarkers in VTE are scarce. We aimed to determine if patients with acute VTE have differences in the proteomics/metabolomic profile. This observational trial included 62 patients with clinical suspicion of acute deep vein thrombosis (DVT) or pulmonary embolism (PE) admitted to the emergency room (ER).

Palavras-chave

Venous Thromboembolism biomarkers Bioarmarkers Metabolomic Proteomic Red Blood Cells Genómica Funcional e Estrutural

URI

http://hdl.handle.net/10400.18/11294

Coleções

DGH - Apresentações orais em encontros internacionais

Licença CC

cclicense-by

Ver registo completo